National Institutes of Health
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
Translational Neural Devices (R61/R33 - Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing January 28, 2027.
Jan 28, 2027
(181d left)